Skip to content

Meet TCG
Our Portfolio
In the News
Join our Ecosystem

Contact Us
Investor Login

Contact Us
Investor Login

June 18, 2019

Dr. JJ Kang Promoted from Principal to Partner

/ TCG News / By admin

The Column Group announces the promotion of Dr. JJ Kang from Principal to Partner. Dr. Kang has been with TCG since 2015.

Post navigation

← Previous Post

In The News

Featured news from our team and portfolio

Thumbnail for The Column Group Raises Over $400 Million For Its New Fund, TCG Labs-Soleil

The Column Group Raises Over $400 Million For Its New Fund, TCG Labs-Soleil

The Column Group launches a novel ‘venture-biotech’ model, creating an integrated ecosystem to exclusively fund, discover, and develop single-asset biologic therapies.

Portfolio News

01.13.25

ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones

01.13.25

Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones

01.13.25

ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations

01.09.25

A2 Biotherapeutics Closes $80 Million Series C Financing to Advance Clinical Development of its Precision Cell Therapies Using its Proprietary Tmod(TM) Technology Platform

01.02.25

Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics

12.23.24

RAPT Therapeutics Announces $150 Million Private Placement

Meet TCG
Our Portfolio
In The News
Join Our Ecosystem
Contact Us
Investor Login

Meet TCG
Join Our Ecosystem
Our Portfolio
Contact Us
In The News
Investor Login

Copyright © 2024. The Column Group

Privacy Policy
Terms of Use

Scroll to Top